User:Tilman Schirmer/Sandbox 201
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
== Intro == | == Intro == | ||
| - | + | ||
== Domain structure == | == Domain structure == | ||
| Line 12: | Line 12: | ||
| - | + | ||
== Protomer == | == Protomer == | ||
| Line 20: | Line 20: | ||
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
| - | + | ||
== Substrate binding site == | == Substrate binding site == | ||
| Line 32: | Line 32: | ||
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
| - | + | ||
== Allosteric product binding site == | == Allosteric product binding site == | ||
| Line 66: | Line 66: | ||
<br><br><br><br> | <br><br><br><br> | ||
| - | + | ||
== Two conformations == | == Two conformations == | ||
| Line 75: | Line 75: | ||
<applet load='1w25' scene='User:Tilman_Schirmer/Sandbox_201/Loose_dimer/3' size='250' frame='true' align='left' caption='non-activated (1w25)' /> <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Tight_dimer/2' size='250' frame='true' align='center' caption='activated (BeF3- modified; 2v0n)' /> | <applet load='1w25' scene='User:Tilman_Schirmer/Sandbox_201/Loose_dimer/3' size='250' frame='true' align='left' caption='non-activated (1w25)' /> <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Tight_dimer/2' size='250' frame='true' align='center' caption='activated (BeF3- modified; 2v0n)' /> | ||
| - | + | ||
== Non-activated conformation == | == Non-activated conformation == | ||
| Line 91: | Line 91: | ||
| - | + | ||
== Activated conformation == | == Activated conformation == | ||
| Line 105: | Line 105: | ||
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
| - | ---- | ||
Revision as of 13:49, 19 June 2009
PleD
Contents |
Intro
Domain structure
Protomer
|
: , ,
Substrate binding site
|
Allosteric product binding site
|
C-di-GMP
Primary inhibition site (Ip)
Secondary inhibition site (Is)
Primary and secondary inhibition sites
Two conformations
non-activated (1w25)
activated (BeF3- modified; 2v0n)
|
|
Non-activated conformation
|
: , ,
Activated conformation
|
